Purpose Of Review: To present an overview of the peer-reviewed literature relating to glucocorticoid-induced osteoporosis that has been published since January 2006.
Recent Findings: Understanding the pathophysiology of bone loss resulting from glucocorticoid use has become clearer. The role of the receptor-activated nuclear factor kappaB-ligand-osteoprotogerin system has been clarified and will likely lead to better targeted therapies.